One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Trusting the True Experts Through Patient-Reported Health Status in Hypertrophic Cardiomyopathy
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Echocardiographic Changes With Aficamten: A Pixel Is Worth 1,024 Bits
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
Unveiling the Unseen: Myosin Inhibitors Cause Reverse Remodeling of Left Ventricular Macrostructure and Microstructure by CMR
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Cardiac Myosin Inhibitors: Is the Emperor Wearing Any Clothes, or Is it Placebo?
Aficamten in Hypertrophic Cardiomyopathy: Roots and Branches of SEQUOIA
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
Cardiac Myosin Inhibition in Obstructive Hypertrophic Cardiomyopathy: Can Aficamten Stand Alone?
Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up
The Apple May Fall Far From the Family Tree in Hypertrophic Cardiomyopathy
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2024 Perioperative Cardiovascular Management for Noncardiac Surgery Guideline-at-a-Glance
